fda restrictions on compounding bpc-157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank An FDA advisory committee voted

An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with Industry Update: Interim 503A and 503B Bulks Lists New Revisions Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law 83% of peptide aware Americans want the FDA to make peptides more accessible AOL Big news for the peptide space., The FDA Pharmacy Compounding Advisory Committee recently voted eight to six in favor of allowing compounding pharmacies to produce BPC 157. Here is what you need to Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest

SKU: 72460764708 · From jacksfamilyfund.org